🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this study is to assess if patients can be retained on long-ter...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07565701
Treatments Being Tested
This is a Phase 1, open-label, 3-arm, fixed sequence, study to evaluate vad...
Status
Completed
Location
inVentiv Health Clinique Inc.
Start Date
2018-07-20
Trial ID
NCT03801759
Treatments Being Tested
To assess the single dose pharmacokinetics (PK) of celecoxib in healthy sub...
Status
Completed
Location
Multiple Locations
Start Date
2015-07
Trial ID
NCT02502500
The purpose of this study is to evaluate the dose response (efficacy), phar...
Status
Completed
Location
Multiple Locations
Start Date
2011-06-15
Trial ID
NCT01381094
This is a multi-center, randomized (1:1), open-label, active-controlled, pr...
Status
Active Not Recruiting
Location
DaVita Research Site
Start Date
2025-07-24
Trial ID
NCT06901505
Treatments Being Tested
This is a healthy volunteers study to assess the bioequivalence of vadadust...
Status
Completed
Location
Paraxel International
Start Date
2018-08-03
Trial ID
NCT03657290
Treatments Being Tested
A multicenter, randomized, open-label, active-controlled Phase 3 study for ...
Status
Completed
Location
Research Site
Start Date
2016-02
Trial ID
NCT02680574
Treatments Being Tested
The primary purpose of this study is to compare the PK parameters of a sing...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT02412449
This study will be conducted to assess the pharmacokinetics of vadadustat 6...
Status
Completed
Location
Research Site
Start Date
2019-05-28
Trial ID
NCT03992066
Treatments Being Tested
This is a Phase 1, three-part, open-label study to evaluate vadadustat as a...
Status
Completed
Location
InVentiv Health Clinique Inc.
Start Date
2018-06-17
Trial ID
NCT03801733
Treatments Being Tested